CNA FINANCIAL CORP quarterly report, Q1 FY2024

CNA Financial Corporation — Q1 2024 Form 10-Q

Reporting period: Three months ended March 31, 2024. Financial statements are unaudited; amounts are in U.S. dollars unless otherwise noted. Loews Corporation owned approximately 92% of CNA at quarter-end.

Financial results and position

MetricQ1 2024Q1 2023 / prior dateChange
Total revenues$3.444 billion$3.152 billionUp 9%
Net earned premiums$2.441 billion$2.248 billionUp 9%
Net investment income$609 million$525 millionUp $84 million
Net investment losses$22 million$35 millionLosses narrowed
Net income$338 million$297 millionUp 14%
Core income, non-GAAP$355 million$325 millionUp 9%
Diluted earnings per share$1.24$1.09Up $0.15
Operating cash flow$504 million$436 millionUp $68 million
Cash$409 million$345 million at Dec. 31, 2023Up $64 million
Total debt$3.520 billion$3.031 billion at Dec. 31, 2023Up $489 million
Stockholders’ equity$9.662 billion$9.893 billion at Dec. 31, 2023Down $231 million

Net cash used in investing activities was $249 million, versus $51 million provided in Q1 2023. Financing activities used $189 million, including $667 million of common dividends, partly offset by $490 million of debt proceeds. The company issued $500 million of 5.125% notes due February 15, 2034. The $550 million of short-term debt was unchanged.

Management said cash flows are sufficient for current and expected working-capital and debt needs, with no near-term change expected. No amounts were outstanding under the $250 million revolving credit facility or through the Federal Home Loan Bank of Chicago at quarter-end.

Operating trends and comparison

  • Core income increased $30 million. Management attributed the improvement primarily to higher investment income and favorable prior-year reserve development, partly offset by higher catastrophe losses.
  • Property & Casualty combined results included $88 million of catastrophe losses, compared with $52 million a year earlier. Prior-year reserve development was favorable by $7 million, versus unfavorable development of $13 million in Q1 2023.
  • Specialty: Core income was $177 million versus $171 million; combined ratio was 90.7% versus 90.0%. Premium growth was modest, while higher acquisition costs and underlying loss costs pressured the ratio.
  • Commercial: Core income was $158 million versus $151 million; combined ratio was 97.6% versus 96.0%. Catastrophe losses rose to $82 million from $44 million. Underlying combined ratio improved to 90.8% from 91.8%.
  • International: Core income was $37 million versus $24 million; combined ratio improved to 93.3% from 97.2%, mainly reflecting the absence of the prior-year quarter’s $15 million unfavorable reserve development. Gross written premiums declined.
  • Life & Group: Core income improved to $5 million from a $3 million loss, primarily due to higher investment income. The segment includes run-off long-term-care business.
  • Corporate & Other: Core loss widened to $22 million from $18 million, including a $5 million after-tax office-consolidation charge.

Outlook, risks, and unusual items

  • The filing provides no specific quantitative earnings or premium guidance. Management’s liquidity statement is that current cash flows should meet near-term working-capital and debt obligations.
  • Common dividends of $2.44 per share were paid in Q1, including a $2.00 special dividend. On May 2, 2024, the board declared a $0.44-per-share quarterly dividend, payable June 6, 2024. Future dividends remain subject to board discretion, business needs, financial condition, and regulatory constraints.
  • Long-term-care reserves depend on estimates extending over decades and may increase if experience is adverse. Q1 included $20 million of immediate net-income charges from certain cohorts whose net premium ratio exceeded 100%, partly offset by $2 million of reversals.
  • Insurance-reserve estimates are exposed to claim severity, medical and repair-cost inflation, litigation and social inflation, legal changes, and catastrophe experience. Management reported $88 million of catastrophe losses in the quarter.
  • The investment portfolio had $3.096 billion of gross unrealized losses on fixed-maturity securities at March 31, 2024, versus $2.995 billion at year-end. Management attributed these losses primarily to interest-rate changes and said it did not intend, and was not more likely than not required, to sell affected securities before recovery.
  • The legacy asbestos and environmental pollution reinsurance arrangement with NICO had $3.6 billion of cumulative ceded losses, a $405 million unrecognized deferred benefit, and $2.6 billion of collateral-trust assets at quarter-end. Recovery depends on the reinsurance arrangement and counterparty performance.
  • Other disclosed risks include reinsurance collectability, reserve adequacy, severe weather and other catastrophes, mass-tort claims, market and credit conditions, regulation, and cybersecurity. The filing says routine litigation currently known is not material. It also discloses approximately $1.5 billion of potential structured-settlement guarantee payments over annuitants’ lifetimes, which management does not believe are likely.

Management reported no material change in market-risk components during the quarter. Disclosure controls were assessed as effective, and no material change in internal control over financial reporting was reported.

Important facts for investors to verify

  • Whether higher catastrophe losses and underlying claims trends persist, particularly in Commercial, and how renewal pricing and retention develop.
  • Whether reserve estimates remain adequate, including long-tail casualty, long-term-care, and warranty exposures, and whether subsequent periods bring favorable or adverse development.
  • Whether investment income gains continue and whether unrealized investment losses, interest rates, or credit conditions affect portfolio values or liquidity.
  • How the new debt issuance, increased debt balance, and large special dividend affect capital flexibility and future dividend capacity.
  • Whether reinsurance counterparties, including NICO, perform as expected and whether collateral and recoverables remain sufficient.